Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Jan 25, 2016; 8(2): 67-76
Published online Jan 25, 2016. doi: 10.4253/wjge.v8.i2.67
Figure 1
Figure 1 Endoscopic ultrasound appearance of mass lesions in pancreas. A: Serous cystic neoplasm of head of pancreas (HOP); B: Neuroendocrine tumor of head of pancreas with dilated pancreatic duct (2) and adjacent portal vein (3); C: Carcinoma HOP with loss of fat planes with confluence of superior mesenteric vein (SMV) and portal vein and dilated common bile duct (1); D: Carcinoma HOP with common bile duct and SMV infiltration.
Figure 2
Figure 2 Contrast enhanced endoscopic ultrasound and endoscopic ultrasound elastography. A and B: Neuroendocrine tumor in the head of pancreas (HOP) before (A) and after (B) contrast administration; C: Fine needle aspiration (FNA) of mass in the HOP; D and E: Carcinoma HOP, EUS elastographic (D) appearance and B mode EUS appearance (E); F: Carcinoma HOP with metastasis (1) in the left lobe of liver.
Figure 3
Figure 3 Endoscopic ultrasound guided interventions. A and B: fiducial placement for mass in the head of pancreas (HOP); C: celiac plexus neurolysis (CA-celiac artery, SMA-superior mesenteric artery); D: fine needle aspiration of mass in the HOP; E radiofrequency ablation (RFA) of mass in the HOP; F,G and H: choledochoduodenostomy for biliary stricture due to mass in the HOP; I and J: hepaticogastrostomy and placement of metal stent.